Identifying Candida albicans Gene Networks Involved in Pathogenicity by Thomas, Graham et al.
ORIGINAL RESEARCH
published: 24 April 2020
doi: 10.3389/fgene.2020.00375
Frontiers in Genetics | www.frontiersin.org 1 April 2020 | Volume 11 | Article 375
Edited by:
Christina A. Cuomo,
Broad Institute, United States
Reviewed by:
David Kadosh,
The University of Texas Health Science
Center at San Antonio, United States
Matt Anderson,
The Ohio State University,
United States
*Correspondence:
Ryan M. Ames
r.ames@exeter.ac.uk
Specialty section:
This article was submitted to
Evolutionary and Genomic
Microbiology,
a section of the journal
Frontiers in Genetics
Received: 29 January 2020
Accepted: 26 March 2020
Published: 24 April 2020
Citation:
Thomas G, Bain JM, Budge S,
Brown AJP and Ames RM (2020)
Identifying Candida albicans Gene
Networks Involved in Pathogenicity.
Front. Genet. 11:375.
doi: 10.3389/fgene.2020.00375
Identifying Candida albicans Gene
Networks Involved in Pathogenicity
Graham Thomas 1, Judith M. Bain 2, Susan Budge 2, Alistair J. P. Brown 2,3 and
Ryan M. Ames 1*
1 Biosciences, University of Exeter, Exeter, United Kingdom, 2 Aberdeen Fungal Group, Institute of Medical Sciences,
University of Aberdeen, Aberdeen, United Kingdom, 3MRC Centre for Medical Mycology at the University of Exeter,
Biosciences, University of Exeter, Exeter, United Kingdom
Candida albicans is a normal member of the human microbiome. It is also an
opportunistic pathogen, which can cause life-threatening systemic infections in severely
immunocompromized individuals. Despite the availability of antifungal drugs, mortality
rates of systemic infections are high and new drugs are needed to overcome therapeutic
challenges including the emergence of drug resistance. Targeting known disease
pathways has been suggested as a promising avenue for the development of new
antifungals. However, <30% of C. albicans genes are verified with experimental
evidence of a gene product, and the full complement of genes involved in important
disease processes is currently unknown. Tools to predict the function of partially or
uncharacterized genes and generate testable hypotheses will, therefore, help to identify
potential targets for new antifungal development. Here, we employ a network-extracted
ontology to leverage publicly available transcriptomics data and identify potential
candidate genes involved in disease processes. A subset of these genes has been
phenotypically screened using available deletion strains and we present preliminary data
that one candidate, PEP8, is involved in hyphal development and immune evasion. This
work demonstrates the utility of network-extracted ontologies in predicting gene function
to generate testable hypotheses that can be applied to pathogenic systems. This could
represent a novel first step to identifying targets for new antifungal therapies.
Keywords: Candida albicans, co-expression network, network-extracted ontology, pathogen, pathogenicity
genes, PEP8
1. INTRODUCTION
Candida albicans is the most common cause of nosocomial fungal infections and is particularly
important in vulnerable populations with suppressed immune function (Brown et al., 2012b).
Mortality rates for systemic candidiasis have been estimated to be as high as 40% (Kullberg and
Arendrup, 2015) and antifungal treatments for these invasive infections have only modest success
in reducing these high rates (Brown et al., 2012a), despite the introduction of new antifungals,
such as the echinocandins (Denning and Bromley, 2015). The discovery and development of
new antifungal drugs to treat these life-threatening infections must overcome several challenges
including the evolutionary similar fundamental cellular processes of humans and fungi, and the
emergence of drug resistance (Denning and Hope, 2010). With high mortality rates, the emergence
of drug resistance and the emergence of other pathogenic fungal species, such as Candida auris
(Chowdhary et al., 2017), there is a drastic need for methods and targets to aid development of
novel antifungal therapies.
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The C. albicans community have employed elegant molecular
and genetic approaches to identify genes involved in disease
processes (Mayer et al., 2013). The key processes involved in
disease are well-known and include; adhesion of yeast cells
to host cell surfaces, morphological transition from yeast
cells to hyphal cells, hyphal invasion by thigmotrophism,
endocytosis, release of candidalysin, micronutrient scavenging,
stress responses, and biofilm formation (Mayer et al., 2013;
Brown A. J. et al., 2014; Brown A. J. P. et al., 2014; Moyes et al.,
2016; Noble et al., 2016; Lohse et al., 2018). Indeed, targeting
of these processes has been proposed as a promising strategy
for antifungal development (Gauwerky et al., 2009; Vila et al.,
2017). However, to identify promising targets we need a detailed
understanding of these processes and, in many cases, the full
complement of genes involved in these pathways is unknown.
In fact, ∼70% of C. albicans genes are uncharacterized (Candida
Genome Database, Nov 2019) and have no experimental
evidence for functional annotation (Skrzypek et al., 2016).
The bioinformatic prediction of genes involved in known
disease processes provides an alternative, complementary
approach to potentially time-consuming experimental screens
for such genes.
In the last decade, high-throughput RNA sequencing methods
have empowered systems-wide studies of cellular organization
and function. Methods to identify differential expression of
genes (Robinson et al., 2010; Love et al., 2014) and infer
gene co-expression networks (Langfelder and Horvath, 2008;
Ames et al., 2013; Kramer et al., 2014) aim to predict the
function of uncharacterized genes. One such method, Clique
Extracted Ontology (CliXO) infers a network-extracted ontology
(NeXO) from gene similarity data, such as correlated gene
expression (Kramer et al., 2014). An ontology consists of entities,
such as groupings or clusters of genes, that are connected by
relationships. The structure is a hierarchy and provides several
advantages over static network representations, as NeXOs are
capable of representing the organization of biological systems
on multiple scales such as pathways, complexes, and individual
genes as well as capturing pleiotropy. In addition, NeXOs
are data-driven and unbiased, enabling de novo modeling of
biological processes that can generate predictions about the
functions of uncharacterized genes for experimental validation.
NeXOs have previously been applied to predict the functions
of uncharacterized genes and identify novel functional links
in yeast (Dutkowski et al., 2013). More recently, NeXOs
have been used to generate hypotheses about autophagy
processes implicated in disease (Kramer et al., 2017) and novel,
disease-related genes in a prominent fungal phytopathogen
(Ames, 2017).
In this study we have assembled publicly available
transcriptomics data for C. albicans and use CliXO to
infer a C. albicans NeXO that represents pathogenicity
without relying on existing annotation. We demonstrate
that this network is robust and can recapitulate known
biological functions. By overlaying the C. albicans NeXO
with data on characterized disease genes, we are able to
make predictions about uncharacterized genes involved in
various disease processes. These genes have putative roles
in adhesion, hyphal development and stress responses.
Furthermore, using available deletion strains we are able
to phenotypically screen a subset of these candidates. Our
data suggest that one such gene, PEP8, might play a role
in hyphal development and immune evasion, which has
also been suggested by other authors. Ultimately, this study
demonstrates the utility of NeXOs to identify functional
links between genes that can be used to generate testable
hypotheses. This has allowed us to identify a potential role for
a partially characterized gene in an important disease process.
These tools therefore, may represent an attractive and cost
effective approach to identifying virulence targets for new
antifungal therapies.
2. MATERIALS AND METHODS
2.1. Calculating Gene Co-expression
RNA-Seq data for C. albicans grown in a number of conditions,
stresses and environments were downloaded from the Gene
Expression Omnibus (GEO) database. These data include
C. albicans grown in YPD and YPS (GSE41749, Grumaz et al.,
2013), in planktonic and biofilm states (GSE45141, Desai et al.,
2013), with a range of weak organic acids (GSE49310, Cottier
et al., 2015), and in contact with host cells (GSE56091, Liu
et al., 2015). In all cases all replicates, treatments and control
data for strain SC5314 were used. In total, 130 RNA-Seq
samples were used, as maximizing the number of samples used
allows us to create the most robust NeXO possible. We note
that the majority of samples were taken from an infection-
related environment composed of C. albicans cells exposed to
endothelial and epithelial cells with RNA taken at 1.5, 5, and
8 h during infection (Liu et al., 2015). Therefore, the NeXO
built in this study will predominantly represent C. albicans
infection processes related to these cell types and timepoints and
is suitable for the application in this study. The addition of more
expression data, from varied environments or infection stages,
would allow the NeXO to represent a broader range of functions
and processes.
Raw data for all publicly available data sets was re-analyzed as
experimental setups and conditions may vary between sources.
The C. albicans (strain SC5314, assembly 22, haplotype A)
reference genome was downloaded from the Candida Genome
Database (CGD, Inglis et al., 2012). RNA-Seq reads were aligned
to the reference genome using bowtie (Langmead et al., 2009)
and bowtie2 (Langmead and Salzberg, 2012) for single-end and
paired-end reads, respectively. Alignment was performed using
default parameters on a single processor and alignment files were
sorted and converted to binary format using samtools (Li et al.,
2009). Reads aligned to known genes were counted using the
union model with HT-Seq (Anders et al., 2014) and these counts
were used to estimate gene expression as reads per kilobase per
million mapped reads (RPKM) with edgeR (Robinson et al.,
2010). By generating estimates of expression from raw data
we ensure that the data is as comparable as possible. Finally,
correlations were calculated for all pairs of genes across all
samples using the Pearson’s correlation coefficient (PCC).
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2.2. Generating a C. albicans NeXO
CliXO was used to create a C. albicans NeXO from correlations
in gene expression (Kramer et al., 2014). CliXO requires a user-
defined noise parameter α and a parameter to infer missing edges
β . CliXO has been benchmarked on several ’omics data sets
for the yeast Saccharomyces cerevisiae, including gene expression
profile correlations, and it has been shown that α = 0.01 and
β = 0.5 produces ontologies that are very similar to that of the
Gene Ontology (GO) (Kramer et al., 2014). Therefore, in this
study α and β were set to 0.01 and 0.5, respectively. Varying these
parameters produces similar NeXO structures. Altering the α
parameter to α = 0.02 produces a NeXO structure where entities
have an average similarity to the reference C. albicans NeXO of
0.66 ± 0.28 (max 1.0) using the alignment and similarity metrics
of Kramer et al. (2014) with a the strict hierarchy model. Varying
the β parameter to β = 0.4 and β = 0.6 also produced a similar
NeXO structure with average entity similarity of 0.83 ± 0.22 and
0.75± 0.23, respectively.
2.3. Aligning the C. albicans NeXO to the
Gene Ontology
The Gene Ontology (GO) structure (OBO file) and annotations
for C. albicans were downloaded from geneontology.org. To
prepare the GO for alignment to the C. albicans NeXO, the
structure of the GO was extracted using “is_a” GO relations,
terms with no annotations to known C. albicans genes were
removed, and redundant terms were removed. Redundant terms
were defined as terms that share the same gene content as
their direct descendants. When redundant terms were identified
the more general term, i.e., the parent, was removed. After
processing of the GO there were 776, 1,919, and 3,804 terms in the
Cellular Component, Molecular Function, and Biological Process
ontologies, respectively. The method of Kramer et al. (2014)
was used to align the C. albicans NeXO to the GO ontologies
using the strict hierarchy model and to generate an alignment for
all nodes.
2.4. Scoring the Robustness of the
C. albicans NeXO
The C. albicans NeXO is split into a number of entities with
hierarchical relationships between them. As these entities will
represent biological pathways and processes it was important
to estimate the robustness of the entities with regard to the
underlying experimental data used to construct the NeXO.
To score the robustness of each term a measure of entity
quality that considers the network support of a term and
its robustness to perturbations of input data was taken from
Dutkowski et al. (2013). In this measure, network support NS(e)
for an entity e is defined as the enrichment for co-expression
between genes within an entity where co-expression is defined
as PCC > 0.2. Enrichment [-log(P-value)] is estimated using the
hypergeometric distribution where the sample size is equal to
all possible co-expressed genes in an entity, sample successes are
the observed co-expressed genes in an entity, the population size
is all possible co-expressed genes in the NeXO, and population
successes are the observed co-expressed genes in the NeXO.
To quantify an entity’s robustness to changes in the input
data, a bootstrapping approach was employed. Samples were
randomly selected with replacement to build an expression set of
130 samples. Correlations for all pairs of genes were calculated
and a NeXO was inferred as described above. This process
was repeated to produce 100 bootstrapped ontologies. Each
bootstrapped NeXO was then aligned to the original NeXO using
the method described in Kramer et al. (2014). Alignment was
performed using the strict hierarchy model and all nodes were
aligned. The bootstrap score B(e) for an entity (e) was then
calculated as:
B(e) =
1
n
n∑
i=1
Si(e) (1)
where n is the number of bootstrapped NeXOs and Si is the
alignment score for entity e when the original NeXO is aligned
to the i-th bootstrapped NeXO. Finally, the robustness score for
each entity was calculated as a geometric mean of the entity’s
network support and bootstrap score:
R(e) =
√
NS(e)B(e) (2)
2.5. Identifying Entities Associated With
Disease
Entities, clusters of genes identified from their correlated
expression profiles, potentially important for disease, were
identified as those containing more than two members and
that show enrichment for genes implicated in disease. Two
sources were used to annotate disease genes; (i) 167 disease
genes identified from the pathogen-host interaction database
(Winnenburg et al., 2006) and (ii) 255 genes that produce
secreted and cell wall proteins thought to be associated with
disease were taken from Butler et al. (2009). Fisher’s exact test
was used to identify enrichment by comparing the proportion of
genes within each entity associated with disease to the proportion
of genes in the whole NeXO associated with disease. The method
of Benjamini and Hochberg (1995) was used to control for a false
discovery rate of 0.05.
2.6. Annotating Entities in the C. albicans
NeXO
Entities within the NeXOwere annotated by identifying enriched
GO terms (Ashburner et al., 2000). The GO slim ontology and
annotations were downloaded from the CGD and Fisher’s exact
test was used to identify enriched GO terms in each entity.
Briefly, for each entity each annotated GO term was tested for
enrichment where the population size was the number of genes
in the C. albicans NeXO and the sample size was the size of
the entity. The population successes are the number of genes in
the C. albicans NeXO (i.e., whole network) annotated with the
specific GO term and the sample successes are the number of
genes within the entity (i.e., a single cluster) annotated with that
term. The method of Benjamini and Hochberg (1995) was used
to control for a false discovery rate of 0.05.
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2.7. Phenotypic Assays
Homozygous deletion strains for genes identified in entities
associated with disease were assembled from Rauceo et al.
(2008) and Noble et al. (2010) in VB GKO plate 1 obtained
from the Fungal Genetics Stock Center (McCluskey et al.,
2010). A full list of strains used in this study can be found
in Supplementary File 1. Strains were stored at −80◦C in 96-
well plates, replicated on agar plates and subjected to a variety
of phenotypic assays including; (i) thermotolerance on YPD at
25, 30, 37, and 42◦C, (ii) osmotic stress with YPD+NaCl and
YPD+KCl at 30◦C at both 0.5 and 1 M; (iii) YPD+H2O2 at
30◦C with concentrations of 2.5, 5, 7.5, and 10 mM; (iv) acidic
environments from pH 4.0 to pH 7.0 at both 30 and 37◦C;
and (v) YPD+Fluconazole and YPD+Caspofungin at 30◦C with
concentrations of 1, 2 µg/ml and 0.064 and 0.128 µg/ml,
respectively. Strains were incubated under these conditions
for 48 h.
2.8. Characterization of Hyphal Growth
Hyphal growth was assessed by first examining colony
morphology on agar plates containing YPD+20% serum
and in Spider medium incubated at 30 and 37◦C for 48 h (Liu
et al., 1994). Second, overnight cultures were diluted to OD600,
incubated in a shaking incubator in liquid YPD containing 20%
serum at 37◦C and cells were fixed in 10% formalin after 90 m so
that hyphal growth could be observed by microscopy.
2.9. Macrophage Escape Assay
Bone marrow was harvested from three eight-week old male
C57BL/6 mice, from which bone marrow derived macrophages
(BMDMs) were differentiated, as described previously (Davies
andGordon, 2005). BMDMswere transferred to a 96-well plate at
2.4× 104 cells per well. C. albicans cells were grown overnight in
YPD and then washed three times in phosphate-buffered saline
(PBS) and resuspended in 1 ml PBS. Following counting, 7.2 ×
104 of C. albicans cells were added to each well, ensuring a 3:1
ratio of yeast to macrophage. YOYO-1 dye (150 µl) was then
added to each well. Fluorescence arising from lysed macrophages
was measured at 30 m intervals for 12 h in a FLUOstar Optima
plate reader (BMG Labtech) using excitation 485 nm/emission
520 nm at 37◦C (Bain et al., 2014).
2.10. Ethical Statement
BMDMs were prepared from three 8-week old male C57BL/6
mice, which were selected randomly, bred in-house, and housed
in stock cages under specific pathogen-free conditions. The mice
did not undergo surgical procedures prior to culling by cervical
dislocation. All animal experimentation was approved by the UK
Home Office and by the University of Aberdeen Animal Welfare
and Ethical Review Body.
3. RESULTS
3.1. A C. albicans NeXO
Expression of C. albicans genes from different growth states,
environments, stresses, and infection models representing 130
individual samples were used to characterize the C. albicans
FIGURE 1 | Venn diagram showing the number of entities in the C. albicans
NeXO (white) that align to Biological Process (BP, red), Molecular Function (MF,
green) or Cellular Component (CC, blue) GO ontologies.
system. Correlated gene expression profiles for 5,698 C. albicans
genes were used to infer a network-extracted ontology (NeXO)
with the CliXO method (Kramer et al., 2014). The resulting
NeXO consists of 1,366 entities connected by 1,801 relationships
where larger entities split into smaller subsets representing
functions on multiple scales. The C. albicansNeXO structure can
be found in Supplementary File 2.
Aligning this C. albicans NeXO to the GO shows that
1,033/1,366 (75.6%) entities can be aligned to at least one
ontology within the GO, with many terms mapping to more
than one (Figure 1). Of the 496 entities that contain more than
4 genes, 336 can be aligned to GO terms. The C. albicans
NeXO captures 70.6% of terms in the Cellular Component
ontology but only captures 18.1 and 20.9% of terms in
the Biological Process and Molecular Function ontologies,
respectively (Supplementary File 3). This suggests that the
C. albicans NeXO largely describes subcellular structures and
macromolecular complexes.
Aligning the C. albicans NeXO to the GO provides
useful information about the similarity between the structure
of the two ontologies. To gain more information about
the function, or multiple functions, of entities within the
C. albicans NeXO, enriched GO terms for each entity were
identified using Fisher’s Exact Test (adjusted P <0.05) and
used as a functional annotation. There are 333/1,366 (24.3%)
entities with significant GO term enrichment and 159/496
(32.0%) entities with significant enrichment when examining
entities with greater than four genes. GO term enrichment
covers terms from all three GO ontologies with 35, 20,
and 23 unique GOslim terms enriched from the biological
process, molecular function, and cellular component ontologies,
respectively (Supplementary File 4). This suggests that our
C. albicans NeXO focusses on a subset of functions across
all GO ontologies with many entities showing no functional
enrichment. These may represent noise in NeXO generation
or the identification of currently unknown or unannotated
pathways and functions.
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FIGURE 2 | (A) The C. albicans co-expression network represented as nodes (genes) connected by edges where genes show correlated expression profiles with
Pearson’s Correlation Coefficient > 0.4. Entities enriched for disease genes, described in Table 1, are highlighted by colored circles and the genes that are part of
these entities are also highlighted. (B) A network-extracted ontology (NeXO) inferred from the co-expression data, organized into entities (nodes) of genes and
connected by relationships (edges). Node sizes represent the number of genes associated with each entity and only entities associated with 10 or more genes are
shown. Node colors represent the robustness of the entities calculated by bootstrap analysis, where darker colors indicate a higher robustness score. Entities
enriched for disease genes, described in Table 1, are highlighted by colored circles.
FIGURE 3 | Entity CLX:6916 in the C. albicans NeXO is enriched for known disease genes in the pathogen-host interaction database (Winnenburg et al., 2006). The
hierarchical structure shows CLX:6916 connected by edges to sub-entities (circles), and the genes (rounded rectangles) contained within the entity. Entities that are
aligned to the Gene Ontology are shown in blue. Genes found in the pathogen-host interaction database are highlighted in green. Enriched Gene Ontology terms are
also shown.
To validate the C. albicans NeXO, robustness scores for
each entity were calculated based on network support from
co-expression and bootstrapping of the input expression
data. We find a strong correlation between term size and
robustness with larger terms being more robust (R2 =
0.87, P = <0.0001 on log transformed data, Figure S1).
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FIGURE 4 | Entity CLX:6889 in the C. albicans NeXO is enriched for known disease genes in the pathogen-host interaction database (Winnenburg et al., 2006). The
hierarchical structure shows CLX:6889 connected by edges to sub-entities (circles), and the genes (rounded rectangles) contained within the entity. Entities that are
aligned to the Gene Ontology are shown in blue. Genes found in the pathogen-host interaction database are highlighted in green. Enriched Gene Ontology terms are
also shown.
FIGURE 5 | (A) Images of colony formation for wild-type (SN250) and pep8
mutants grown on Spider media at 37◦C for 48 h. (B) Evidence of reduced
hyphal formation by pep81 cells compared to wild-type cells fixed in formalin
at 90 m hyphal development.
Therefore, the larger entities in the NeXO are more robust.
Excluding entities with fewer than 10 members yields a
mean robustness score of 4.47 compared to 0.82 when all
entities are analyzed. There were two clear outliers: these
were two entities immediately under the root, which both
contain >5,400 genes and are far larger than any other
entities in the NeXO (Figure S1), suggesting that these may
FIGURE 6 | The lysis of macrophages was assayed by measuring release of
the fluorescent dye, YOYO-1 (section Materials and Methods). The pep81
mutant (dark blue) displays a reduced ability to lyse and escape macrophages
compared to the control wild-type strains RM1000 (green; Mann–Whitney U,
***P = 5.875e-11) and SN250 (brown; Mann–Whitney U, **P = 0.002).
Uninfected macrophages (light blue, Control 1; purple, Control 2), and a
hypha-deficient cph11 efg11 mutant (Lo et al., 1997) (red, Ca80) were also
included as controls.
be spurious entities. Overall, entities within the C. albicans
NeXO, particularly larger entities, are robust to the underlying
data suggesting that the addition or removal of data wouldn’t
change their composition and so they are likely to represent
biological functions.
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TABLE 1 | Co-expression entities enriched for known disease genes in the
pathogen-host interaction database.
Co-expression entity Num genes Num disease genes Praw Padj
CLX:6916 24 5 4.92E-4 0.019
CLX:6951 33 6 2.91E-4 0.014
CLX:7006 75 9 2.55E-4 0.016
CLX:6939 30 6 1.67E-4 0.016
CLX:7039 181 14 6.16E-4 0.019
CLX:7028 139 13 1.51E-4 0.029
CLX:6857 16 4 8.97E-4 0.024
CLX:6889 19 4 0.001 0.043
Praw Fisher’s exact test p-value. Padj Adjusted p-value to control for a false discovery rate
of 0.05 (Benjamini and Hochberg, 1995).
3.2. The C. albicans NeXO Contains
Entities Enriched for Disease Genes
Although many entities in the NeXO were annotated by
identifying enriched GO terms, many remain unannotated
(Figure 1). The unannotated entities may represent
understudied, functionally-related genes with roles in
pathogenicity that are lacking GO annotation. To identify
entities related to pathogenesis irrespective of GO annotation,
we identified entities enriched for known disease genes in the
pathogen-host interaction database (Winnenburg et al., 2006)
(Figure 2). This is a major advantage of using a data-driven
NeXO that can complement existing GO annotation but can also
discover new entities with roles in specific biological processes.
Eight entities within the C. albicans NeXO are enriched for
known disease genes. Six of these eight entities are also enriched
for the GO term “pathogenesis” (GO:0009405) indicating that
the genes in these entities are related to disease. Additionally,
several other terms related to C. albicans disease processes
are also enriched in these entities. GO terms “interspecies
interaction between organisms” (GO:0044419), “filamentous
growth” (GO:0030447), and “growth of unicellular organism as a
thread of attached cells” (GO:0070783) are all regularly enriched
in putative disease-related entities. However, entities CLX:6939
and CLX:6889 show no GO enrichment and may represent areas
of unstudied function associated with disease that have only been
detected using this approach.
3.3. Entities Enriched for Known Disease
Genes Predict New Candidates Associated
With Disease
In those entities that are enriched for known disease genes,
many other genes are uncharacterized and could potentially
be involved in disease processes. In this way we can predict
functional annotations for genes not present in literature-curated
sources such as the GO. The entity CLX:6916 (Figure 3), contains
24 genes with 5 genes annotated as being part of the disease
process in the pathogen-host interaction database (Winnenburg
et al., 2006). Of the other 19 genes in this entity 6 genes have
experimental annotation in the CGD and the remaining 11 genes
are uncharacterized. CLX:6916 is a highly connected entity with
189 edges with a Pearson correlation coefficient>0.2, suggesting
that the genes in this entity may be functionally related. The
entity CLX:6916 contains genes involved in the disease process.
These include RCN1 (C6_01160W), which encodes a calcineurin-
dependent signaling protein that has a role in controlling the
stress response and virulence (Reedy et al., 2010). The genes
VPS24 (C2_00930C) and C6_02690C have been linked to the
processes of adherence Marchais et al. (2005) and hyphal growth
(Bensen et al., 2004), respectively. Also, the entity CLX:6857
(Figure S2) contains the gene TRY5 (C6_01500C), which acts
as a regulator of adhesion genes (Finkel et al., 2012). These
entities display tight clustering suggesting that the genes they
contain are functionally related. Since these entities are enriched
for known disease genes, we reasoned that the uncharacterized
genes in these entities may also play roles in disease and
C. albicans pathogenicity.
3.4. Entities With No Known Functional
Annotation May Represent Understudied
Cellular Processes
Entity CLX:6889 (Figure 4) shows enrichment for known disease
genes but no significant enrichment for any GO terms. CLX:6889
may represent an understudied process, detectable directly
from transcriptomic data using the NeXO approach, where
incorrect or missing GO term annotation means we cannot
detect any significant GO term enrichment or existing functional
annotation. Interestingly, CLX:6939 (Figure S3) shows no GO
term enrichment. However, its descendent entities, CLX:6819
and CLX:6036, are enriched for multiple GO terms. Possible
interpretations again include the possibility of missing GO
term annotation, or that CLX:6939 represents multiple disease-
related processes with no coherent GO description while the
descendent entities CLX:6819 and CLX:6036 represent singular
functions with adequate GO descriptions. In these entities we
find that the majority of genes annotated with GO terms have
been annotated on the basis of sequence similarity or inferred
from electronic annotation, with few terms annotated by mutant
phenotypes or from direct assays. This suggests that the GO
annotations for these genes may be inaccurate or incomplete.
Indeed,∼70% of C. albicans genes are uncharacterized (Candida
GenomeDatabase, Nov 2019) and have no experimental evidence
for functional annotation (Skrzypek et al., 2016). Together, the
enrichment of known disease genes in this entity and the lack
of experimental annotation of GO terms, may suggest that
these entities, and their genes, represent coherent, but under-
characterized, functional units related to disease.
The entity CLX:6889 (Figure 4) contains characterized genes
involved in biofilm production (MRPL33—C3_01080W) (Nett
et al., 2009) and response to mouse macrophages (RPS14B—
C1_06450C) (Lorenz et al., 2004). Both of these genes have
not been shown to contribute to the disease process, but
have functions associated with disease. CLX:6889 also contains
uncharacterized genes that are induced in response to stress
(C5_04300C), involved in protein secretion (C5_01900C) and
involved in the response to macrophages (THS1) (Nobile et al.,
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2012). These have inferred functions potentially related to
disease. These entities suggest that some genes, that may have
been partially characterized or annotated with GO terms, might
yet have undiscovered functions involved in the disease process,
which might be niche-specific, for example.
3.5. Phenotypic Analysis of Mutant Strains
To test whether some partially characterized genes might have
undiscovered functions involved in the disease process, we
selected available, homozygous null mutants corresponding to
genes associated with disease-related entities in the NeXO
(AHR1, WOR2, CST20, GRR1, HGC1, HOG1, HST7, HWP1,
INT1, PBS2, PEP8, RIM101, RSR1, SEF1, TRY5 HIT1, NVL6) and
irrespective of GO annotation. The mutants were subjected to
a range of phenotypic assays alongside their respective control
strains (CAI4+Clp10, RM1000+Clp20, SN250). These virulence-
related assays included yeast-hypha morphogenesis, macrophage
phagocytosis, thermotolerance, resistance to osmotic, oxidative
and acid stresses, and sensitivity to the antifungal drugs,
fluconazole, and caspofungin (Figure S4).
There were detectable phenotypes for mutant strains in a
range of conditions. Several mutants (HIT1, NVL6, HOG1, PBS2)
showed differing levels of sensitivity to YPD+H2O2, particularly
at concentrations of 7.5 and 10 mM. We also observed potential
reduced growth of hit11 when exposed to fluconazole and
rsr11 when treated with caspofungin. Finally, pep81, showed
an aberrant colony morphology on Spider medium (Figure 5).
Whilst the control strain, SN250, displayed the distinctive
wrinkly appearance associated with hyphal development, pep81
colonies were smooth, similar to the appearance of hwp11
colonies with known hyphal abnormalities, suggesting a potential
defect in hyphal development (Figure S4).
3.6. Pep8 Promotes Hypha Formation
To explore the potential defect of pep81 cells in hyphal
development, we compared their morphology to control cells
(SN250) after growth in YPD containing 20% serum at 37◦C
(Figure 5B). The pep81 cells formed stunted hyphae compared
to the control. This confirmed that the loss of Pep8 either delays
or stunts hyphal development in C. albicans, suggesting that Pep8
plays a role in hyphal development.
The formation of hyphae after phagocytosis is known to
promote the escape of C. albicans cells from innate immune
cells (Lo et al., 1997; McKenzie et al., 2010). Therefore, we
reasoned that, given their attenuated hypha formation, pep81
cells might be less able to lyse and escape macrophages
following phagocytosis. We tested this by comparing the ability
of C. albicans strains to promote the release of the fluorescent
dye, YOYO-1, from macrophages (Figure 6). Macrophages
infected with wild type C. albicans control strains (SN250
or RM1000+CIp20) released significant amounts of the dye
over the time course, whereas uninfected macrophages did not.
Also, macrophages infected with the hypha-defective C. albicans
cph11 efg11 mutant did not display significant levels of lysis
(Figure 6), which was consistent with the role that hypha
formation plays in fungal escape from macrophages (Lo et al.,
1997; McKenzie et al., 2010). Significantly, the pep81 cells
displayed a reduced ability to lyse the macrophages compared to
the wild-type controls RM1000 (Mann–Whitney U, P = 5.875e-
11) and SN250 (Mann–Whitney U, P = 0.002). However, the
pep81 cells were able to escape these innate immune cells to
some degree (Figure 6). This was entirely consistent with our
observation that loss of Pep8 partially attenuates, but does not
completely block, hypha formation (Figure 6). We conclude that
Pep8 plays a role in hyphal development and defects in this
gene’s function affect the ability of C. albicans to evade the host
immune system.
4. DISCUSSION
Ontologies extracted from network data have been used
to predict novel, disease-related genes in an important
phytopathogen (Ames, 2017) and identify the function of
uncharacterized genes that can be experimentally validated
(Dutkowski et al., 2013). In this study, we compiled RNA-Seq
data for the human fungal pathogen C. albicans, inferred a NeXO
from correlated expression profiles, and overlaid information on
known disease genes to make functional predictions for poorly-
and un-characterized genes. A subset of these predictions were
then tested using phenotypic screens and infection assays to
identify potentially novel disease-related genes.
NeXOs have been proposed as useful tools to predict a
range of cellular phenotypes and answer important biological
questions (Carvunis and Ideker, 2014). These network structures
have proven to be robust (Dutkowski et al., 2013), as is
the C. albicans NeXO (Figure S1). NeXOs also recapitulate
known functions; a NeXO built from a range of interaction
data for S. cerevisiae aligns to many GO categories and best
represents the Cellular Component ontology (Dutkowski et al.,
2013). The same pattern can be seen in this study with
many entities aligning to GO terms and best representing the
Cellular Component ontology (Figure 1). Previous work looking
at functional modules identified from a yeast co-expression
network shows that many (>80%) Biological Process and
Cellular Component terms can be represented by co-expression
data (Ames et al., 2013). These results therefore suggest that the
structure of NeXOs may be well suited to representing Cellular
Component terms. To better represent biological processes and
molecular functions, methods of generating NeXOs may have
to take into account functional links between genes whose
expression could be dispersed over time. Indeed, sequential
activation of functionally related genes has been demonstrated
during differentiation and development (Queva et al., 1998), cell
wall stress in S. cerevisiae (Bermejo et al., 2008) and C. albicans-
host interactions (Wilson et al., 2009).
Based on location in a NeXO and functions of characterized
genes in the same entity, it is possible to generate hypotheses
about the functions of poorly- or un-characterized genes. Here,
we used enrichment of disease-associated genes in entities
as evidence that these entities may represent disease related
pathways containing as yet unknown disease genes. CLX:6916
(Figure 3) is enriched for disease-associated genes with virulence
related functions, RSR1 (CR_02140W) guides hyphal growth
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(Hausauer et al., 2005), IRS4 (C3_03660W) contributes to
hyphal formation (Badrane et al., 2005), HGC1 (C1_00780C)
regulates hyphal morphogenesis (Zheng et al., 2004), CDC11
(C5_00070W) is also involved in hyphal morphology (Warenda
et al., 2003) and HWP1 (C4_03570W) encodes a major protein
in the cell wall and functions in cell-surface adhesion (Staab and
Sundstrom, 1998; Staab et al., 2004). This entity also contains
several characterized genes that have implicated roles in disease
but are not present in the pathogen-host interaction database.
GRR1 (C5_04600C) is required for cell cycle progression and
involved in the negative control of pseudohyphal growth (Butler
et al., 2006) and RCN1 (C6_01160W) is a calcineurin-dependent
signaling protein that controls stress response and virulence
(Reedy et al., 2010). The identification of entities containing
known disease genes not found in the pathogen-host interaction
database highlights the reliability of these methods and also the
usefulness of using pre-existing databases without the need to
include expert or literature-curated knowledge. There are also
several partially or uncharacterized genes, that have been linked
to the disease process. For example PEP8, a partially characterized
gene, has previously been associated with filamentation in a
large-scale haploinsufficiency assay (Uhl et al., 2003).
A homozygous pep81/pep81 deletion strain was included
in the strains phenotypically assayed in this study. We find
that pep81 cells produce delayed or stunted hyphae and show
attenuated macrophage escape (Figures 5, 6), confirming a role
for this gene in filamentation as previously reported (Uhl et al.,
2003) and suggesting a role in infection. This finding also
confirms recent work, which is entirely independent from this
study, that has shown that pep8 mutants demonstrate severe
filamentation defects in a range of conditions (Azadmanesh
et al., 2017) and these mutants abrogate azole resistance
(Mount et al., 2018). Loss of function of Pep8 abrogates
azole resistance by overwhelming the functional capacity of
calcineurin. Interestingly, PEP8 is clustered with RCN1, which
encodes a calcineurin-dependent signaling protein, among other
genes involved in filamentation and drug resistance. We note
that not all the strains phenotypically tested appear to have roles
in virulence-related processes with the recall and precision of
these approaches estimated to be 0.43 and 0.31, respectively
(Yu et al., 2019). However, given that NeXOs are data-driven
and can be generated quickly with little expert knowledge or
human intervention, they provide useful approaches for the
identification of novel pathways, prediction of functions and
generation of testable hypotheses, especially in those organisms
that lack comprehensive annotation.
This work also demonstrates the utility of NeXOs to reveal
functions at multiple levels. Entities CLX:6916 (Figure 3),
CLX:6088 (Figure S2) and CLX:7006 all contain the hyphal cell
wall protein Hwp1. This indicates that the C. albicans NeXO
is capturing function at different levels and may indicate a
role for Hwp1 in several disease related pathways. CLX:6088
and CLX:7006 both seem to be specifically associated with
cell adhesion based on alignment to the GO and enrichment
for GO terms, respectively (Supplementary Files 3, 4). These
entities are children of the much larger entity CLX:7055 (2,764
members), that shows enrichment for multiple disease-related
GO terms including “pathogenesis,” “cell adhesion,” and “biofilm
formation,” and may represent a higher, or more general,
description of pathogenicity. CLX:6916 appears to be associated
with yeast-hypha morphogenesis and hypha function. The
entity is enriched for terms relating to “filamentous growth”
(GO:0030447), “site of polarized growth” (GO:0030427) and
“pseudohyphal growth” (GO:0007124). The presence of Hwp1 in
entities related to adhesion and hyphal growth tallies perfectly
with the known presence of Hwp1 on the surface of hyphal
cells and the protein’s role in adhesion (Staab and Sundstrom,
1998; Staab et al., 1999). The ontological view allows us to
identify the importance of Hwp1 in multiple-related processes
that are important for pathogenesis. This is a major advantage
of organizing these data into a NeXO to identify relations
between entities, highlight genes present in multiple pathways or
processes and find entities that represent function on different
scales (Dutkowski et al., 2013).
NeXOs may also provide a tool for the functional annotation
of poorly characterized genes (Dutkowski et al., 2013). The
entity, CLX:6889 (Figure 4), shows an enrichment of disease-
associated genes, but does not align to any term in the GO
and has no enrichment for GO terms despite all genes having
GO annotations. Although descendants of CLX:6889 do align
to the GO and CLX:6514 is enriched for the GO term for
pathogenesis (GO:0009405). The members of CLX:6889 include:
HOG1 (C2_03330C) which encodes the stress activated protein
kinase involved in the core stress response (Alonso-Monge et al.,
2009), MLT1 (C1_08210C) a vacuolar membrane transporter
that is needed for virulence (Theiss et al., 2002), MNT2
(C3_01830C) a transferase with a role in adherence and virulence
(Munro et al., 2005), and MDS3 (C3_07320W) encoding a
TOR signaling pathway component required for growth and
hyphal formation (Davis et al., 2002; Richard et al., 2005).
Other genes in this entity, both verified and uncharacterized,
have roles that can be linked to disease processes. For example,
a putative metallodipeptidase (C5_04300C) is a target gene
of a small network of transcription regulators that control
biofilm development (Nobile et al., 2012) and is targeted for
sumoylation, where sumoylation targets have been shown to
have roles in cell cycle progression and stress responses (Leach
et al., 2011). The genes in this entity have varied roles and seem
loosely to be related to growth and its regulation. Although this
entity might be produced by a random clustering of genes, the
enrichment for disease-associated genes and functions assigned
to the entity’s descendents suggests CLX:6889 may represent
a true functional module related to disease not described by
current GO annotations. Indeed, most of the GO annotations
for genes in this entity are inferred from electronic annotation
rather than direct experimental evidence and previous work
using network extracted ontologies has shown that entities that
do not align to the GO can represent true biological modules
(Dutkowski et al., 2013). The genes in this entity therefore,
may represent new targets for functional characterization related
to pathogenesis.
In this study, we use a C. albicans NeXO to generate
testable hypotheses about this important fungal pathogen. It
is important to note that the underlying data used to infer
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NeXOs is crucial to the types of questions that can be answered.
The C. albicans NeXO, leverages publicly available data and
is largely constructed from infection-related data (see section
Materials and Methods), making it well suited to generating
hypotheses about infection-related processes. This may be why
the NeXO is useful to identify groups of genes related to hyphal
development and similar pathogenic processes. However, we note
that other processes are clearly represented by the C. albicans
NeXO, with 24% of entities enriched for GO terms across all
3 Gene Ontologies and only 2˜% of entities enriched with the
“pathogenesis” GO term. Previous studies have used NeXOs to
describe broad functional categories for the yeast S. cerevisiae
and generate hypotheses about the function of uncharacterized
genes (Dutkowski et al., 2013). This was made possible by
utilizing integrated data from protein-protein interactions, gene
co-expression and genetic interactions, which represent varied
areas of biological function (Ames et al., 2013). Therefore, the
addition of further data, both for different infection scenarios
and environments, would produce a C. albicans NeXO that
represents more varied areas of biological function and may well
increase alignment to the GO. Likewise, the addition of known
disease genes from the literature to supplement the pathogen-
host interaction database would increase our set of known disease
genes and may well allow the identification of further disease
processes in the NeXO. Nevertheless, the data used in this study
have been able to recapitulate known functions (Figure 1) and
generate hypotheses for the role of several uncharacterized genes
in disease processes (Figures 3, 4, Figures S2, S3). Even though
only a handful of genes predicted to be involved in disease were
available from the FGSC, we were still able to identify PEP8
as having a potential role in hyphal development and immune
system evasion.
5. CONCLUSION
Here, we have built a NeXO for C. albicans, leveraging publicly
available data, to identify novel gene networks involved in
pathogenicity. We have shown that the NeXO is robust and
recapitulates known biology by aligning to the GO. By identifying
enrichment of known disease genes in entities we make
predictions about pathways and partially or uncharacterized
genes potentially involved in pathogenicity. One such gene, PEP8,
is shown to produce stunted or delayed hyphae and attenuated
immune system evasion. This work, along with that of others,
suggests further characterization of PEP8would be important for
a more detailed understanding of infection processes. This study,
therefore, shows the utility of NeXOs for pathway identification,
functional annotation, and hypothesis generation that can be
applied to multiple systems and processes.
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